CorMedix Inc. reported earnings results for the fourth quarter ended December 31, 2023. For the fourth quarter, the company reported net loss was USD 14.75 million compared to USD 8.21 million a year ago. Basic loss per share from continuing operations was USD 0.26 compared to USD 0.2 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.17 USD | -4.44% | -11.47% | +37.50% |
05-09 | Transcript : CorMedix Inc., Q1 2024 Earnings Call, May 09, 2024 | |
05-09 | CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+37.50% | 284M | |
+7.91% | 72.81B | |
+12.64% | 9.13B | |
-10.56% | 5.13B | |
+58.79% | 4.99B | |
+4.07% | 3.9B | |
-16.90% | 2.48B | |
-26.13% | 2.32B | |
+19.31% | 2.17B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- CRMD Stock
- News CorMedix Inc.
- CorMedix Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023